Randomized phase II study of pemetrexed and cisplatin as either induction or adjuvant chemotherapy in stage IB-II non-small cell lung cancer.

Trial Profile

Randomized phase II study of pemetrexed and cisplatin as either induction or adjuvant chemotherapy in stage IB-II non-small cell lung cancer.

Discontinued
Phase of Trial: Phase II

Latest Information Update: 25 Oct 2015

At a glance

  • Drugs Cisplatin; Pemetrexed
  • Indications Non-small cell lung cancer
  • Focus Adverse reactions
  • Most Recent Events

    • 26 Jul 2012 Actual end date (July 2008) added as reported by ClinicalTrials.gov.
    • 31 Aug 2009 Status changed from active, no longer recruiting to discontinued.
    • 01 Aug 2009 Results have been presented at the 13th World Conference on Lung Cancer.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top